Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. (Q44941336)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. |
scientific article |
Statements
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression (English)
Azra Raza
Silvia Buonamici
Laurie Lisak
Sarah Tahir
Donglan Li
Mehnaz Imran
Nusrat Ijaz Chaudary
Hassan Pervaiz
J Alejandro Gallegos
M Imran Alvi
Muhammad Mumtaz
Sefer Gezer
Poluru Reddy
Naomi Galili
Anna Candoni
Giuseppina Nucifora
1 August 2004